Fang, Yi
Hardy, Rebecca
Yaffe, Kristine
Little, Simon J.
Tanner, Caroline M.
Leng, Yue
Funding for this research was provided by:
National Institute on Aging (R01AG083836)
Article History
Received: 4 June 2025
Accepted: 2 November 2025
First Online: 14 December 2025
Competing interests
: SL has previously been consulted for Iota Biosciences. CMT declares consultancies for CNS Ratings, Australian Parkinson’s Mission, Biogen, Evidera, Cadent (data safety monitoring board), Adamas (steering committee), Biogen (via the Parkinson Study Group steering committee), Praxis (via the International Parkinsons and Movement Disorders Society), Kyowa Kirin (advisory board), Lundbeck (advisory board), Jazz/Cavion (steering committee), Acorda (advisory board), Bial (DMC) and Genentech. CMT also declares grant support to her institution from The Michael J. Fox Foundation, National Institutes of Health, Gateway LLC, Department of Defense, Roche Genentech, Biogen, Parkinson Foundation and Marcus Program in Precision Medicine. CMT declares membership on the editorial boards for the Journal of Parkinson’s Disease and the Journal of Neurology. The other authors declare no competing interests.